Supercell Biotechnology
Taipei, Taiwan· Est.
Taiwanese stem‑cell banking and cell‑therapy service provider with proprietary serum‑free culture technology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwanese stem‑cell banking and cell‑therapy service provider with proprietary serum‑free culture technology.
Regenerative MedicineImmunology
Technology Platform
Proprietary serum‑free culture medium combined with GMP‑grade cryopreservation and comprehensive cell‑quality testing for cord blood, peripheral blood, adipose‑derived, and NK cells.
Opportunities
Expansion into cell‑therapy manufacturing partnerships and growth in Asian stem‑cell banking demand.
Risk Factors
Regulatory hurdles for therapeutic cell products and competition from larger, globally integrated cell‑banking firms.
Competitive Landscape
Competes with regional cord‑blood banks and cell‑therapy platforms; differentiates via serum‑free culture patents and a broad portfolio of cell types.